Similarly, The Endocrine Society endorses genetic counseling and testing to patients with multiple endocrine neoplasia type 1 (MEN1) and also to their first-degree relatives to check for inherited endocrinopathies which are rare and are linked with substantial morbidity and mortality (Gallagher et al., 2017). This evidence concerns the gene MEN1 and endocrine system disorder.